SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-23-026022
Filing Date
2023-09-15
Accepted
2023-09-15 16:15:27
Documents
74
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K inbp20230630_10k.htm   iXBRL 10-K 1238712
2 EXHIBIT 21 SUBSIDIARIES OF THE REGISTRANT ex_524429.htm EX-21 7144
3 EXHIBIT 23 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex_524432.htm EX-23.1 2816
4 EXHIBIT 23.2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex_567561.htm EX-23.2 3311
5 EXHIBIT 31.1 CERTIFICATION OF CO-CEOS ex_524430.htm EX-31.1 20502
6 EXHIBIT 31.2 CERTIFICATION OF CFO ex_524431.htm EX-31.2 17671
7 EXHIBIT 32.1 CERTIFICATION OF CO-CEOS PURSUANT TO 18 USC ex_524433.htm EX-32.1 8667
8 EXHIBIT 32.2 CERTIFICATION OF CFO PURSUANT TO 18 USC ex_524434.htm EX-32.2 7056
  Complete submission text file 0001437749-23-026022.txt   6995637

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA inbp-20230630.xsd EX-101.SCH 60497
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20230630_cal.xml EX-101.CAL 47456
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20230630_def.xml EX-101.DEF 462244
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20230630_lab.xml EX-101.LAB 393355
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20230630_pre.xml EX-101.PRE 489464
68 EXTRACTED XBRL INSTANCE DOCUMENT inbp20230630_10k_htm.xml XML 1098845
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-31668 | Film No.: 231258928
SIC: 2834 Pharmaceutical Preparations